The Effect of Short Periods of Caloric Restriction on Weight Loss and Glycemic Control in Type 2 Diabetes
- Katherine V Williams, MD,
- Monica L Mullen, MPH,
- David E Kelley, MD and
- Rena R Wing, PHD
- Department of Medicine, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania
- Division of Endocrinology and Metabolism Department of Psychiatry, University of Pittsburgh School of Medicine Pittsburgh, Pennsylvania
- Address correspondence to Katherine V. Williams, MD, and reprint requests to Rena R. Wing, PhD, Western Psychiatric Institute and Clinic, Suite 600 Iroquois, 3811 O'Hara Street, Pittsburgh, PA 15213. E-mail (K.YW): kvw+@.pitt.edu
Abstract
OBJECTIVE To determine whether an intermittent very-low-calorie diet (VLCD) improves weight loss and glycemic control more than moderate caloric restriction alone.
RESEARCH DESIGN AND METHODS Individuals with type 2 diabetes (n = 54) who were ≥ 20% over ideal body weight participated in a 20-week behavioral weight control program. Subjects were randomized to either a standard behavioral therapy (SBT) group or to one of two VLCD groups. SBT subjects received a 1,500−1,800 kcal/day diet throughout. Both VLCD groups followed a VLCD for 5 consecutive days during week 2, followed by either intermittent VLCD therapy for 1 day/week for 15 weeks (1-day) or for 5 consecutive days every 5 weeks (5-day), with a 1,500−1,800 kcal/day diet at other times.
RESULTS Both VLCD groups lost more weight than the SBT group over the 20 weeks (P = 0.04). Although the groups did not differ in fasting plasma glucose (FPG) changes at 20 weeks, more subjects in the 5-day group attained a normal HbA1c when compared with the SBT group (P = 0.04). This benefit was independent of the effects of weight loss. The best predictor of overall change in FPG and HbA1c was the FPG response during the first 3 weeks of the program.
CONCLUSIONS Periodic VLCDs improved weight loss in diabetic subjects. A regimen with intermittent 5-day VLCD therapy seemed particularly promising, because more subjects in this group attained a normal HbA1c. Moreover, the glucose response to a 3-week period of diet therapy predicted glycemic response at 20 weeks, and it was a better predictor of the 20-week response than initial or overall weight loss.
- Received April 14, 1997.
- Accepted September 8, 1997.
- Copyright © 1998 by the American Diabetes Association











